Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells

Journal of Biomedical Research

Volumn 24, Issue 1, 2010, Pages 58-63

  Wei, Bingbing ^a   Feng, Ninghan ^a   Zhou, Feng ^b   Lu, Chun ^b   Su, Jiantang ^a   Hua, Lixin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

HIV 1; Prostate cancer; Tat

Indexed keywords

LENTIVIRUS VECTOR; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS TITRATION; WESTERN BLOTTING;

EID: 78449274229     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60009-7     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
3. Areste C, Blackbourn DJ Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol 2009, 17:119-129.
4. Verma V, Shen D, Sieving PC, Chan CC The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol 2008, 53:312-331.
5. Ryan JL, Morgan DR, Dominguez RL, Thorne LB, Elmore SH, Mino-Kenudson M, et al. High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest 2009, 89:80-90.
6. Brady G, Macarthur GJ, Farrell PJ Epstein-Barr virus and Burkitt lymphoma. Postgrad Med J 2008, 84:372-377.
7. Lehoux M, D'Abramo CM, Archambault J Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 2009, 12:268-280.
8. Dubina M, Goldenberg G Viral-associated nonmelanoma skin cancers: A review. Am J Dermatopathol 2009, 31:561-573.
9. Deligeoroglou E, Christopoulos P, Aravantinos L, Papadias K Human papilloma virus molecular profile and mechanisms of cancerogenesis: A review. Eur J Gynaecol Oncol 2009, 30:128-132.
10. Molho-Pessach V, Lotem M Viral carcinogenesis in skin cancer. Curr Probl Dermatol 2007, 35:39-51.
11. Liao JB Viruses and human cancer. Yale J Biol Med 2006, 79:115-122.
12. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 2009, 19:438-451.
13. McGivern DR, Lemon SM Tumor suppressors, chromosomal instability, and hepatitis c virus-associated liver cancer. Annu Rev Pathol 2009, 4:399-415.
14. McBride G Hepatitis b virus-induced liver cancer in Asian Americans: A preventable disease. J Natl Cancer Inst 2008, 100:528-529.
15. Moore PS, Gao SJ, Dominguez G, Cesarman E, Lungu O, Knowles DM, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 1996, 70:549-558.
16. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995, 268:582-583.
17. Renne R, Lagunoff M, Zhong W, Ganem D The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 1996, 70:8151-8154.
18. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995, 1:707-708.
19. Smith MS, Bloomer C, Horvat R, Goldstein E, Casparian JM, Chandran B Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997, 176:84-93.
20. Sarid R, Olsen SJ, Moore PS Kaposi's sarcoma-associated herpesvirus: Epidemiology, virology, and molecular biology. Adv Virus Res 1999, 52:139-232.
21. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948-954.
22. Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996, 334:1168-1172.
23. Hoffman LJ, Bunker CH, Pellett PE, Trump DL, Patrick AL, Dollard SC, et al. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 2004, 189:15-20.
24. Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM, et al. Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 2000, 82:718-725.
25. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, et al. Intracellular tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: Role of jak/stat signaling. J Virol 2007, 81:2401-2417.